The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers
- 1 January 1991
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 31 (1) , 81-87
- https://doi.org/10.1002/j.1552-4604.1991.tb01891.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Iloprost, ein stabiles Prostacyclinderivat, bei arterieller Verschlußkrankheit im Stadium IV: Eine placebo-kontrollierte MultizenterstudieDeutsche Medizinische Wochenschrift (1946), 1989
- Ciprostene in patients with peripheral vascular disease (PVD). An open-label, tolerance trialProstaglandins, Leukotrienes & Essential Fatty Acids, 1988
- Fate in intermittent claudication: outcome and risk factors.BMJ, 1986
- Synthesis of 9-substituted carbacyclin analogsThe Journal of Organic Chemistry, 1983
- Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.British Journal of Clinical Pharmacology, 1982
- A controlled study showing significant short term effect of prostaglandin el in healing of ischaemic ulcers of the lower limb in manProstaglandins, Leukotrienes and Medicine, 1982
- Vasodilator Drugs in Peripheral Vascular DiseaseNew England Journal of Medicine, 1979
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- The Natural Course of Arteriosclerosis of the Lower ExtremitiesAngiology, 1960
- THE CASE AGAINST VASODILATOR DRUGS IN OCCLUSIVE VASCULAR DISEASE OF THE LEGSThe Lancet, 1959